Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia

• Liangliang Wu,
• Limin Liu,
• Xin Zhao,
• Ming Zhou,
• Andie Fu,
• Yuping Zhang,
• Wenrui Yang,
• Xiaowei Chen,
• Wenjian Mo,
• Caixia Wang,
• Yumiao Li,
• Shilin Xu,
• Shiyi Pan,
• Ruiqing Zhou,
• Fankai Meng,
• Fengkui Zhang,
• Depei Wu,
• Shunqing Wang

Affiliations

Liangliang Wu

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Limin Liu

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University

Xin Zhao

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Anemia Therapeutic Center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Ming Zhou

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Andie Fu

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Yuping Zhang

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Wenrui Yang

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Anemia Therapeutic Center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Xiaowei Chen

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Wenjian Mo

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Caixia Wang

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Yumiao Li

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Shilin Xu

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Shiyi Pan

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Ruiqing Zhou

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology

Fankai Meng

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Fengkui Zhang

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Anemia Therapeutic Center, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Depei Wu

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University

Shunqing Wang

Department of Hematology, Guangzhou First People’s Hospital, South China University of Technology